Literature DB >> 25640985

The enzymatic activities of brain catechol-O-methyltransferase (COMT) and methionine sulphoxide reductase are correlated in a COMT Val/Met allele-dependent fashion.

Jackob Moskovitz1, Consuelo Walss-Bass2, Dianne A Cruz3, Peter M Thompson3, Jenaqua Hairston1, Marco Bortolato1.   

Abstract

AIMS: The enzyme catechol-O-methyltransferase (COMT) plays a primary role in the metabolism of catecholamine neurotransmitters and is implicated in the modulation of cognitive and emotional responses. The best characterized single nucleotide polymorphism (SNP) of the COMT gene consists of a valine (Val)-to-methionine (Met) substitution at codon 108/158. The Met-containing variant confers a marked reduction in COMT catalytic activity. We recently showed that the activity of recombinant COMT is positively regulated by the enzyme Met sulphoxide reductase (MSR), which counters the oxidation of Met residues of proteins. The current study was designed to assess whether brain COMT activity may be correlated to MSR in an allele-dependent fashion.
METHODS: COMT and MSR activities were measured from post-mortem samples of prefrontal cortices, striata and cerebella of 32 subjects by using catechol and dabsyl-Met sulphoxide as substrates, respectively. Allelic discrimination of COMT Val(108/185) Met SNP was performed using the Taqman 5'nuclease assay.
RESULTS: Our studies revealed that, in homozygous carriers of Met, but not Val alleles, the activity of COMT and MSR was significantly correlated throughout all tested brain regions.
CONCLUSION: These results suggest that the reduced enzymatic activity of Met-containing COMT may be secondary to Met sulphoxidation and point to MSR as a key molecular determinant for the modulation of COMT activity.
© 2015 British Neuropathological Society.

Entities:  

Keywords:  Met oxidation; catechol-O-methyltransferase; gene polymorphism; oxidative stress; post-mortem human brain

Mesh:

Substances:

Year:  2015        PMID: 25640985      PMCID: PMC4500745          DOI: 10.1111/nan.12219

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  73 in total

1.  Oestrogen metabolism in lymphangioleiomyomatosis: catechol-O-methyltransferase pathway is not involved.

Authors:  B Paquette; P K Fortier; J Héroux; P A Thibodeau; R Wagner; J Liu; A Cantin
Journal:  Thorax       Date:  2000-07       Impact factor: 9.139

2.  Analysis of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association with aggressive and antisocial behavior.

Authors:  R D Strous; N Bark; S S Parsia; J Volavka; H M Lachman
Journal:  Psychiatry Res       Date:  1997-03-24       Impact factor: 3.222

Review 3.  Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors.

Authors:  P T Männistö; S Kaakkola
Journal:  Pharmacol Rev       Date:  1999-12       Impact factor: 25.468

4.  Effect of catechol-O-methyltransferase val158met genotype on attentional control.

Authors:  Giuseppe Blasi; Venkata S Mattay; Alessandro Bertolino; Brita Elvevåg; Joseph H Callicott; Saumitra Das; Bhaskar S Kolachana; Michael F Egan; Terry E Goldberg; Daniel R Weinberger
Journal:  J Neurosci       Date:  2005-05-18       Impact factor: 6.167

5.  Association analysis of the catechol O-methyltransferase gene and bipolar affective disorder.

Authors:  B Gutiérrez; J Bertranpetit; R Guillamat; V Vallès; M J Arranz; R Kerwin; L Fañanás
Journal:  Am J Psychiatry       Date:  1997-01       Impact factor: 18.112

6.  Association between catechol-O-methyltransferase Val(108/158)Met polymorphism and psychotic features of bipolar disorder.

Authors:  Francesco Benedetti; Sara Dallaspezia; Cristina Colombo; Cristina Lorenzi; Adele Pirovano; Enrico Smeraldi
Journal:  J Affect Disord       Date:  2010-02-01       Impact factor: 4.839

7.  Concordance of DSM-IV Axis I and II diagnoses by personal and informant's interview.

Authors:  Barbara Schneider; Konrad Maurer; Dieter Sargk; Harald Heiskel; Bernhard Weber; Lutz Frölich; Klaus Georgi; Jürgen Fritze; Andreas Seidler
Journal:  Psychiatry Res       Date:  2004-06-30       Impact factor: 3.222

Review 8.  Gene-sex interactions in schizophrenia: focus on dopamine neurotransmission.

Authors:  Sean C Godar; Marco Bortolato
Journal:  Front Behav Neurosci       Date:  2014-03-06       Impact factor: 3.558

9.  Low activity allele of catechol-O-methyltransferase gene associated with rapid cycling bipolar disorder.

Authors:  G Kirov; K C Murphy; M J Arranz; I Jones; F McCandles; H Kunugi; R M Murray; P McGuffin; D A Collier; M J Owen; N Craddock
Journal:  Mol Psychiatry       Date:  1998-07       Impact factor: 15.992

10.  No evidence for an association of affective disorders with high- or low-activity allele of catechol-o-methyltransferase gene.

Authors:  H Kunugi; H P Vallada; F Hoda; G Kirov; M Gill; K J Aitchison; D Ball; M J Arranz; R M Murray; D A Collier
Journal:  Biol Psychiatry       Date:  1997-08-15       Impact factor: 13.382

View more
  4 in total

1.  Manic symptom severity correlates with COMT activity in the striatum: A post-mortem study.

Authors:  Marco Bortolato; Consuelo Walss-Bass; Peter M Thompson; Jackob Moskovitz
Journal:  World J Biol Psychiatry       Date:  2016-07-26       Impact factor: 4.132

Review 2.  The Functions of the Mammalian Methionine Sulfoxide Reductase System and Related Diseases.

Authors:  Beichen Jiang; Jackob Moskovitz
Journal:  Antioxidants (Basel)       Date:  2018-09-18

3.  µ-Opioid Activity in Chronic TMD Pain Is Associated with COMT Polymorphism.

Authors:  T D Nascimento; N Yang; D Salman; H Jassar; N Kaciroti; E Bellile; T Danciu; R Koeppe; C Stohler; J K Zubieta; V Ellingrod; A F DaSilva
Journal:  J Dent Res       Date:  2019-09-06       Impact factor: 8.924

4.  Opioid response in paediatric cancer patients and the Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene: an Italian study on 87 cancer children and a systematic review.

Authors:  Ersilia Lucenteforte; Alfredo Vannacci; Giada Crescioli; Niccolò Lombardi; Laura Vagnoli; Laura Giunti; Valentina Cetica; Maria Luisa Coniglio; Alessandra Pugi; Roberto Bonaiuti; Maurizio Aricò; Sabrina Giglio; Andrea Messeri; Roberto Barale; Lisa Giovannelli; Alessandro Mugelli; Valentina Maggini
Journal:  BMC Cancer       Date:  2019-01-31       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.